𝔖 Bobbio Scriptorium

✦ LIBER ✦

735 POSTER Randomized comparison of capecitabine plus oxaliplatin (CapOx) versus capecitabine plus gemcitabine (CapGem) versus gemcitabine plus oxaliplatin (GemOx) in advanced pancreatic cancer

Book ID: 118623311
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 206 KB
Volume: 3
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(05)81030-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN22 ECONOMIC ANALYSIS OF CAPECITABINE

PCN22 ECONOMIC ANALYSIS OF CAPECITABINE PLUS OXALIPLATIN (XELOX) VERSUS FLUOROURACIL/LEUCOVORIN PLUS OXALIPLATIN (FOLFOX) IN THE TREATMENT OF ADVANCED GASTRIC CANCER IN CHINA

✍ Chen, W 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

PCN66 ECONOMIC ANALYSIS OF CAPECITABINE

PCN66 ECONOMIC ANALYSIS OF CAPECITABINE PLUS OXALIPLATIN (XELOX) VERSUS FLUOROURACIL/LEUCOVORIN PLUS OXALIPLATIN (FOLFOX) IN THE TREATMENT OF ADVANCED COLON-RECTUM CANCER IN CHINA

✍ W Chen 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

PS11 Best of ECCO 13 Phase III randomise

PS11 Best of ECCO 13 Phase III randomised comparison of gemcitabine (GEM) versus gemcitabine plus capecitabine (GEM-CAP) in patients with advanced pancreatic cancer

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 66 KB

3029 POSTER A Swiss multicentre phase II

3029 POSTER A Swiss multicentre phase II study of capecitabine plus oxaliplatin (CAPOX) in combination with preoperative pelvic radiotherapy in patients (pts) with locally advanced rectal cancer

✍ D. Köberle; R. Burkhard; R. Von Moos; R. Winterhalder; V. Hess; F. Heitzmann; T. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 59 KB

A phase III randomized comparison of lap

A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses

✍ David Cameron; Michelle Casey; Michael Press; Deborah Lindquist; Tadeusz Pienkow 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 330 KB

717 ORAL Gemcitabine (GEM) plus capecita

717 ORAL Gemcitabine (GEM) plus capecitabine (CAP) versus GEM alone in locally advanced or metastatic pancreatic cancer. aspects of quality of life in a randomized phase III study of the Swiss Group for Clinical Cancer Research (SAKK) and the Central European Cooperative Oncology Group (CECOG)

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 261 KB